Adherence to HIV treatment significantly increases survival, researchers find
(Medical Xpress)—HIV-positive individuals who strictly adhere to highly active antiretroviral therapy (HAART) have a significantly lower probability of premature morbidity and mortality as compared to those with suboptimal compliance to HAART, according to a new study from the BC Centre for Excellence in HIV/AIDS (BC-CfE).
The study, published this week in the peer-reviewed journal PLOS ONE, investigated 3,543 HIV-infected individuals who were more than 19 years old and had never been on HAART when they started treatment between January 1, 2000 and August 31, 2009. Participants were followed until their death due to any cause, or if alive, until the last contact date or August 31, 2010, whichever came first. At the end of the follow-up period from 2000 to 2010, 499 (14 per cent) deaths were recorded.
Researchers at the BC-CfE developed and validated a new metric, the Programmatic Compliance Score (PCS), to assess the impact of non-compliance with HIV treatment guidelines on mortality among HIV-positive individuals on therapy within a fully subsidized antiretroviral therapy program. The PCS was based on the BC-CfE therapeutic guidelines, which are consistent with the International AIDS Society
-USA (IAS-USA) antiretroviral therapy management guidelines. The researchers hypothesized that non-compliance would be associated with the highest probability of premature death.
Based on the IAS-USA guidelines, the PCS is composed of six non-performance indicators: having less than three CD4 (immunity affected by HIV) count tests in the first year after starting antiretroviral therapy; having less than three plasma viral load (viral replication) tests in the first year after starting antiretroviral therapy; no drug resistance testing prior to starting treatment; starting on a non-recommended antiretroviral therapy regimen; starting therapy with CD4 <200 cells/mm3; and not achieving HIV viral load suppression within six months since starting treatment. The sum of these six indicators was used to develop the PCS score with zero indicating full compliance and six indicating most non-compliance.
The study found that each PCS component was highly associated with mortality, even after adjusting for several important demographical and clinical factors. However, individuals with a PCS score of four or higher were 22 times more likely to die than those with a PCS score of zero.
"The study results independently validate IAS-USA HIV therapeutic guidelines," said Dr. Julio Montaner, senior author of the study, director of the BC-CfE and head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia. "The findings highlight the importance of adhering to treatment as per the guidelines, especially during the first year on HAART, to ensure that we can optimize the benefits derived from treatment as it relates to decreasing morbidity and mortality, and secondarily preventing new HIV infections."
The study only used information collected during the first year on therapy to predict the risk of mortality. The first year on antiretroviral therapy is very important in a patient's treatment history, as it often dictates the trajectory the disease will follow. This is particularly critical with regards to HIV, which has a great capacity to mutate into harder to treat variants when it is exposed to suboptimal regimens or if there is incomplete adherence to the treatment.
"PCS is a simple and highly predictive metric of mortality among HIV-positive individuals who have started treatment for the first time," said Dr. Viviane Lima, lead author of the study and senior statistician at the BC-CfE. "These results provide valuable insights for health providers and administrative bodies in B.C. and internationally to develop strategies that will assist us to help patients adhere to treatment and improve health outcomes."
In British Columbia, the B.C.-pioneered Treatment as Prevention strategy has led to the widespread expansion of HAART coverage. The BC-CfE has demonstrated that the benefits of early HAART treatment are twofold: it reduces the level of HIV in the blood to undetectable levels thus improving the health of people with HIV, and decreases the level of HIV in sexual fluids to undetectable levels thus reducing the likelihood of HIV transmission by more than 96 per cent.
Despite the undisputable benefits of HAART, it is still not clear which metrics, at the individual and the population levels, should be used to monitor and evaluate the impact of this powerful intervention. The PCS metric, developed by the BC-CfE, can prove an effective predictor of mortality and help better manage patients on treatment. Further efforts are needed to enhance the PCS as a means to further improve clinical outcomes.
More information: Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy, PLOS One. dx.plos.org/10.137… pone.0047859
Journal reference: PLoS ONE
Provided by University of British Columbia
- Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs Jun 07, 2010 | not rated yet | 0
- Increased mortality in HIV-positive South African men versus women is unrelated to HIV/AIDS Sep 04, 2012 | not rated yet | 0
- Roll out treatment as prevention now to stop HIV and AIDS Jul 14, 2011 | not rated yet | 0
- HIV prevention strategy key to curbing epidemic and cutting long-term treatment costs Jul 07, 2010 | not rated yet | 0
- New study adds further guidance on when to start antiretroviral therapy for HIV Sep 26, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
HIV & AIDS 22 hours ago | not rated yet | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
HIV & AIDS May 18, 2013 | 5 / 5 (2) | 0
Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...
HIV & AIDS May 17, 2013 | not rated yet | 0
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.
HIV & AIDS May 17, 2013 | not rated yet | 0
A new Yale study looks at the scope and consequences of a burgeoning health problem in the cities of the U.S. Northeast: concurrent infection with both HIV and Hepatitis C (HCV). The study appears online ...
HIV & AIDS May 17, 2013 | not rated yet | 0
When tumours metastasise, they can block lymphatic vessels, as researchers from ETH Zurich have discovered using a new method. The lymphatic fluid subsequently has to find a new path through the tissue. Such ...
27 minutes ago | not rated yet | 0 |
(Medical Xpress)—Flinders University researchers are breaking new ground in a decade-long journey to pinpoint the function of two closely related proteins.
17 minutes ago | not rated yet | 0 |
(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...
6 minutes ago | not rated yet | 0 |
(Medical Xpress)—Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused ...
6 minutes ago | not rated yet | 0
Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. In his doctoral thesis Yue Shen from the Industrial ...
26 minutes ago | not rated yet | 0
(Medical Xpress)—The feared Legionella pneumophila is responsible for legionellosis, an infectious disease that can lead to pneumonia. To infect humans, this pathogen has developed a complex method that allows it to camouflage ...
36 minutes ago | not rated yet | 0